Rapid Expansion in the POCT Market
POCT Technology market set to reach USD 75.0 billion by 2030
Read more hereCutting-Edge Advances in POCT
Next-generation technologies reshaping healthcare services
Secure your placePOCT Data Syncs with Health Systems
Incorporation of remote POC devices with Electronic Healthcare Records
View the latest programExpert Speakers to Date
- Mike Ulman
West Pharmaceutical Services, Inc. - Grant Knappe
Massachusetts Institute of Technology - Patrick Reeves
Harvard Medical School - Ashwin Singhania
Ernst & Young - Joseph Kim
ProofPilot - Karthik Raman
Persist AI Formulations Corp. - Luke Heywood
Nest Scientific USA - Moritz Von Stosch
DataHow AG - Martin Kachele
IDT Biologika GmbH - Lan Hu
Viome Life Sciences, Inc.
Past Attendees
- Moderna, Inc.
- Mayo Clinic
- Harvard University
- Human Metabolome Technologies America Inc.
- Massachusetts General Hospital
- ProofPilot
- Brain Performance Center
- Massachusetts Institute of Technology
- Quantoom Biosciences
- AstraZeneca
- Seventure
- University of Wisconsin
- Icahn School of Medicine at Mount Sinai
- CLINEXEL Life Sciences
- Pontchartrain Cancer Center
Who should attend
- Laboratories
- Diagnostic Centers
- Community Hospitals
- Tertiary Hospitals
- Health Systems
- Cancer Centers
- Critical Care
- Emergency Care
- Physicians
- Pathology
- Nursing
- Pharmacies
- Digital Health
- Medical Devices
- Clinical Engineering
- Patient Quality & Safety
- Population Health Management
- Regulatory Affairs
- Equipment Certification Services
- Health Insurance
- News Reporting and Journalism
- Healthcare Organizations
- Healthcare Service Providers
- Health Insurance Providers
- Medical Device Companies
- Pharmaceutical Companies
- Laboratories
- POCT Companies
- Microfluidics
- Nanotechnology
- Diagnostic Startups
- Healthcare Software Providers
- Artificial Intelligence Companies
- IoT Companies
- Researchers
- Investors and Venture Capitalists
- Government Agencies
- Consultants and Advisors
- Public Consultation Groups
- Legal and Compliance Services
- News Reporters and Journalists
- Patients and Patient Advocates
Why Attend
The POCT TECHNOLOGY USA 2024 exhibition and conference is the only event, delivering leading market intelligence and industry presentations on the latest innovations in POCT to advance global healthcare.
view more...Subscribe for updates:
The Exclusive Forum for Point-of-Care-Testing Technologies
Welcome to the POCT TECHNOLOGY USA 2024 Exhibition and Conference, where industry leaders will meet to explore the latest advancements in Point-of-Care-Testing Technology and innovative healthcare practices.
The global healthcare industry faces challenges such as inefficient resource management, limited patient engagement, and healthcare disparities. Point-of-Care-Testing Technology emerges as a solution, enhancing healthcare efficiency by delivering rapid, reliable test results and critical diagnostic data to improve patient outcomes.
Join us to forge connections, drive innovation, and transform healthcare through cutting-edge technologies.
This year’s POCT TECHNOLOGY USA 2024 will be the world’s leading exhibition and conference exclusively for healthcare professionals, offering a platform for collaboration with POCT innovators and advanced diagnostic companies. Attendees will gain insights into new methods and technical expertise for advancing global healthcare innovation.
Key topics on this year’s agenda include:
- Global healthcare trends driven by Point-of-Care-Testing Technologies
- Enhanced diagnostic precision through advanced technology integration
- Cutting-edge research in testing technologies to improve disease diagnosis
- Development of lab-quality, multi-assay diagnostic tests on a single chip
- Case studies on POCT in remote chronic disease management
- Navigating regulations and standardization of POCT through new channels
This exhibition and conference will serve as a forum for stakeholders across the healthcare industry to network, build cross-market relationships, and address POCT Technology challenges driven by the imperative to cut healthcare costs.
Call for Presentation
If you would like to be a speaker at this event, please contact sean.collins@iQ-Hub.com with the subject heading "Call for Papers – POCT TECHNOLOGY USA 2024".
To secure your place at POCT TECHNOLOGY USA 2024 or for more information, please email delegates@iQ-Hub.com.
Key topics for 2024:
-
Global Healthcare Trends Driven by Point-of-Care Testing Technology
Explore state-of-the-art forecasts in point-of-care technology in the contemporary global healthcare landscape -
Enhanced diagnostic precision through advanced technology integration
Understand the integration of AI, IoT, and ML with POCT devices to revolutionize diagnostics -
Cutting-edge research in testing technologies to improve disease diagnosis
Familiarize with diverse disease testing methods enhanced by point-of-care diagnostics -
Development of lab-quality, multi-assay diagnostic tests on a single chip
Gain insights into Lab-on-a-Chip platforms translating POCT with microfluidics, nano biosensors and miniaturized devices -
Case studies on POCT in remote chronic disease management
Recognize next-generation smart POT's role in chronic healthcare through remote monitoring and antibiotic stewardship -
Navigating regulations and standardization of POCT through new channels
Learn from policymakers about regulatory approvals and reimbursement models for decentralized testing
Testimonials
- Very interesting event with a broad range of topics addressing the most current problems in the healthcare sector
Martin Kachele (IDT Biologika GmbH) - The event was well organized with interesting content applicable to any organization
Kelly Benesky (Merck) - This conference presented an interesting mix of academics and innovators covering a wide range of topics in the healthcare field
Mike Ulman (West Pharmaceutical Services) - The congress supplied us with exceptional insights on employing technologies
Emre Tureli (MyBiotech) - I enjoyed the broad range of topics discussed during the summit. I was exposed to a wide range of valuable subjects
Donny Hoy (AstraZeneca)